Blindness Completed Phase 2 Trials for Melatonin (DB01065)

Also known as: Blind / Blindness NOS

IndicationStatusPhase
DBCOND0009476 (Blindness)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00972075Efficacy and Safety of Circadin for Non-24 Hour Sleep-Wake Disorder in Totally Blind SubjectsTreatment